Pfizer intends to send data on the 4th Covid shot soon, and work on vaccines for all variants.

Pfizer plans to submit data to the Food and Drug Administration soon for a fourth shot of Covid, and it is working on a vaccine that protects against all variants of the coronavirus, CEO Albert Bourla told CNBC on Friday.

“I think we’re going to be submitting to the FDA a significant data advance on the need for a fourth dose, and they need to draw their own conclusions, of course, and the CDC as well. …Obviously. It is clear that it is necessary to have Bourla said in an interview on “Box of Squaw. ”

“We’re making a vaccine that includes omicron and all the other variants. There’s a lot of trials going on right now and a lot of them we’ll start reading at the end of the month,” he said. continue afterwards. he’s optimistic from the preliminary data he sees.

Bourla’s comments come exactly two years after Covid was declared a pandemic by the World Health Organization on March 11, 2020, and the global economy shut down.

• Anti-pandemic measures followed, including mandatory mask wearing and travel restrictions, and then a major breakthrough came when a Covid vaccine was developed and approved. use.
• Since then, approximately 81.4% of the U.S. population 5 years of age and older have received at least one dose of the three published doses of vaccine in the United States from Pfizer, Moderna and Johnson & Johnsonaccording to Centers for Disease Control and Prevention.
• Currently, daily Covid cases and deaths have decline since peaking in January of this year due to the omicron wave. Some states raised authorized masks in schools and other public places.
• Companies consists of Google and Apple called workers return to the office. Businesses, including restaurants, entertainment venues and more, have also reopened.

Despite some signs of a return to normal, Bourla insists he remains cautious about creating an effective vaccine. “I think the biggest question we all have is how to overcome the virus.”

He said Pfizer was working on developing a vaccine that would prevent infections in addition to preventing hospitalizations and serious cases caused by the virus, adding that the production of the vaccine was not enough. -Please have a long-lasting effect is also a priority.

“We can’t have a vaccine every five, six months,” Bourla said. “We need to move as soon as possible.”